Health authorities dismiss reports of insulin shortage, cite unavailability of one brand

ISLAMABAD: Authorities on Tuesday denied reports of a widespread insulin shortage in the country, saying that only one brand was unavailable due to international supply constraints. The clarification came after reports of a shortage across Pakistan emerged on social media. The health ministry and the Drug Regulatory Authority of Pakistan (Drap) maintained that alternatives for the unavailable brand remained available in the market. “Insulin glulisine (Apidra, Sanofi) is currently unavailable due to international supply constraints. Alternate rapid-acting analogues within the same pharmacologic